Trials / Completed
CompletedNCT01514825
A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects
YM150 Clinical Pharmacology Study - Repeated Oral Administration to Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 65 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and plasma concentration change of YM150 after repeated administration to healthy elderly male and female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM150 | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2006-11-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2012-01-23
- Last updated
- 2012-01-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01514825. Inclusion in this directory is not an endorsement.